Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection

Br J Haematol. 2023 Jun;201(6):e62-e65. doi: 10.1111/bjh.18827. Epub 2023 Apr 21.

Authors

F Peracchi^{1

2}, M Merli¹, C Rogati¹, E Ravano³, M Puoti^{1

2}, R Cairoli^{2

3}, G Travi¹

Affiliations

¹ Division of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
² School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
³ Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

PMID: 37085972
DOI: 10.1111/bjh.18827

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / therapeutic use
COVID-19*
Humans
SARS-CoV-2

Substances

Antiviral Agents